查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1809888

GMP 細胞庫服務市場（按服務類型、細胞類型、細胞庫類型、應用和最終用戶分類）—2025 年至 2030 年全球預測

GMP Cell Banking Services Market by Service Type, Cell Type, Cell Bank Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

GMP細胞庫服務市場預計將從2024年的9.9639億美元成長到2025年的11.1327億美元，複合年成長率為12.10%，到2030年將達到19.7796億美元。

主要市場統計數據
基準年2024年 9.9639億美元
預計2025年 1,113,270,000美元
預測年份 2030 19.7796億美元
複合年成長率（%） 12.10%

推出以嚴格的品管、先進的生物加工突破和全球供應鏈整合為驅動力的精準細胞庫解決方案

GMP細胞庫領域不斷發展，已成為現代生物製藥開發的重要支柱，推動創新並確保關鍵生技藥品的可重複性。隨著企業努力提高細胞株穩定性並簡化生產流程，強大的品管措施和先進的生物製程平台已成為成功細胞庫策略不可或缺的要素。精準工程與嚴謹監管的結合，提高了人們對製程一致性、產品安全性和可追溯性的期望。

新技術與監管變革如何重新定義全球GMP細胞庫實務的標準

近年來，技術創新和監管變革的交匯再形成了GMP細胞庫的格局。如今，自動化高通量平台能夠以極少的人工干預處理複雜的樣品製備和活力評估，從而提高可重複性並降低污染風險。同時，由人工智慧演算法驅動的數位過程控制系統能夠實現預測性維護和自適應回饋迴路，從而維持最佳培養條件。

評估2025年美國關稅對品質主導的細胞庫和全球生物製藥供應安全的深遠影響

2025年美國新關稅的實施，為依賴跨國採購關鍵試劑和設備的細胞庫企業帶來了複雜的策略考量。專用培養基成分、冷凍保護劑和一次性耗材等原料的進口關稅將上調，迫使企業重新評估籌資策略和供應鏈配置。

揭示細胞庫市場在細胞類型、產品線、應用、最終用戶、供應來源、規模、儲存、加工方法和分銷管道方面的詳細細分

細胞庫市場的複雜性源自於細胞類型的多樣性，每種細胞類型都有其獨特的特性和需求。 Sf21、Sf9 和 Tn5 等昆蟲細胞株擅長高產蛋白表達，但需要獨特的培養條件和病毒載體系統。 CHO 和 HEK293 細胞等哺乳動物宿主為治療性糖蛋白提供了無與倫比的兼容性，而 NS0 和融合瘤系則支持單株抗體的生產。微生物平台同樣涵蓋細菌系統，例如芽孢桿菌和大腸桿菌菌株，以及酵母宿主，例如畢赤酵母和釀酒酵母，每個平台都兼顧了快速生長和轉譯後修飾能力。

揭示影響美洲、歐洲、中東和非洲以及亞太市場細胞銀行創新和採用模式的區域動態

地理動態對GMP細胞庫解決方案的開發和實施有重大影響。北美和拉丁美洲憑藉其成熟的法律規範和專業的人才儲備，已經建立了生物製藥中心網路。在拉丁美洲，成本結構和物流效率正在推動對區域生產中心的策略性投資，以補充該地區的臨床試驗需求，尤其是在生物相似藥和疫苗方面。

介紹推動全球生物製造領域技術創新、卓越營運和策略合作的領先細胞庫服務供應商

GMP細胞庫領域的領先服務供應商以其對技術領先地位、營運擴充性和協作敏捷性的追求而聞名。多家全球性公司已建立多設施佈局，整合自動化低溫保存設備和先進的分析平台，支援高容量樣本處理。這些機構擁有豐富的試劑和耗材庫存，以確保快速的周轉時間，並最大限度地減少供應鏈中斷。

產業領導者在推動GMP細胞庫營運合規性、可擴展性和創新方面的策略挑戰和主動舉措

產業領導者若希望利用不斷發展的GMP細胞庫環境，應優先考慮對自動化和數位監控工具進行策略性投資。透過整合即時分析和流程控制演算法，企業可以顯著降低差異性並加快產品發布週期。同時，透過區域採購夥伴關係和舉措實現供應路線多元化，可以增強企業應對關稅引發的成本壓力和運輸瓶頸的能力。

透明而嚴謹的混合調查方法為全面分析 GMP 細胞庫市場趨勢和競爭格局奠定了基礎

該分析基於嚴格的混合方法框架，整合了基礎研究、二手資料審查和專家檢驗。初始階段包括與各相關人員的深入訪談，包括細胞庫管理層、品質保證專家、監管顧問和設備供應商。這些對話提供了關於營運痛點、技術採用障礙和策略重點的定性見解。

綜合洞察，掌握未來機會，應對不斷發展的 GMP 細胞庫生態系統中的挑戰

GMP細胞庫產業正面臨前所未有的技術進步、監管調整和地緣政治影響，相關人員必須整合多方面的洞見，制定更具韌性的發展路徑。新的模式在於協調自動化流程管理、敏捷的供應鏈和協作創新生態系統，以滿足對生物治療藥物和細胞產品日益成長的需求。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 擴展 GMP 細胞庫的自動化程度，以提高可重複性和通量
  • 實施封閉的生物程序，最大限度地降低細胞庫生產過程中的污染風險
  • 整合即時分析和數位監控增強了 GMP 細胞庫的品質保證
  • 同種異體細胞療法的引入正在推動可擴展 GMP 細胞庫基礎設施和容量的需求
  • 標準化冷凍保存通訊協定以提高治療細胞庫的長期穩定性和活力
  • CDMO與生物技術公司之間的策略夥伴關係擴大了區域GMP細胞庫網路的影響力
  • 監管協調努力將簡化細胞庫GMP級細胞治療產品的國際核准

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. GMP細胞庫服務市場（依服務類型）

  • 細胞銀行和儲存
  • 細胞株開發與表徵
  • 監管支持和文件
  • 測試和品管
    • 外來性病原體檢測
    • 基因穩定性測試
    • 背景調查
    • 純度測試
    • 無菌測試

9. GMP細胞庫服務市場（依細胞類型）

  • 昆蟲細胞
  • 哺乳動物細胞
    • CHO細胞
    • HEK293細胞
    • NS0/Sp2細胞
    • Vero細胞
  • 微生物細胞
    • 細菌細胞
    • 酵母菌細胞
  • 幹細胞
    • 胚胎幹細胞
    • 誘導性多功能幹細胞（iPSC）
    • 間質幹細胞（MSCs）

10. GMP細胞庫服務市場（依細胞庫類型）

  • 停產細胞庫（EOPCB）
  • 主細胞庫（MCB）
  • 研究細胞庫（RCB）
  • 工作細胞庫（WCB）

第 11 章 GMP 細胞庫服務市場（按應用）

  • 生物製藥製造
    • 基因和細胞治療
    • 單株抗體
    • 重組蛋白
    • 疫苗
  • 細胞療法
  • 藥物研發
  • 組織工程與再生醫學

第 12 章 GMP 細胞庫服務市場（按最終用戶）

  • 學術研究機構
  • 合約研究與製造組織
  • 醫院和診所
  • 製藥和生物技術公司

13.美洲GMP細胞庫服務市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14.歐洲、中東和非洲GMP細胞庫服務市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15.亞太地區GMP細胞庫服務市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • 53Biologics
    • Austrianova
    • Cell Culture Company, LLC
    • Charles River Laboratories
    • Clean Cells
    • Eurofins Scientific Limited
    • ExcellGene SA
    • Goodwin Biotechnology Inc.
    • Kaneka Eurogentec SA
    • Lonza Group Ltd.
    • Merck KGaA
    • NAOBIOS
    • PackGene Biotech lnc.
    • ProBio Biotech Corporation
    • RoslinCT
    • SGS Group
    • SK pharmteco Inc.
    • Takara Bio Inc.
    • Texcell SA
    • uBriGene Biosciences International Co.
    • ViruSure GmbH
    • Wacker Chemie AG
    • WuXi Biologics
    • OmniaBio
    • eXmoor pharma concepts ltd

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-E336711C9F91

The GMP Cell Banking Services Market was valued at USD 996.39 million in 2024 and is projected to grow to USD 1,113.27 million in 2025, with a CAGR of 12.10%, reaching USD 1,977.96 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 996.39 million
Estimated Year [2025] USD 1,113.27 million
Forecast Year [2030] USD 1,977.96 million
CAGR (%) 12.10%

Heralding the Dawn of Precision Cell Banking Solutions Fueled by Rigorous Quality Controls, Advanced Bioprocessing Breakthroughs, and Global Supply Chain Integration

The evolving field of GMP cell banking has become an indispensable pillar of modern biopharmaceutical development, driving innovation and ensuring the reproducibility of critical biologics. As organizations endeavor to enhance their cell line stability and streamline production workflows, robust quality control measures and advanced bioprocessing platforms have emerged as nonnegotiable components of any successful cell banking strategy. The convergence of precision engineering and regulatory rigor has elevated expectations for process consistency, product safety, and traceability.

Consequently, industry leaders are embracing automated systems that integrate real-time monitoring with stringent data capture protocols, enabling tighter control over every stage of the cell banking journey. Furthermore, breakthroughs in cryopreservation and lyophilization techniques are extending cell viability windows and reducing logistical risks across global supply chains. Collectively, these advances are reshaping traditional paradigms, allowing manufacturers to respond more nimbly to evolving therapeutic demands.

Looking ahead, the interplay between next-generation analytics, digital twins, and predictive modeling promises to further transform how cell banks are designed, scaled, and qualified. By anticipating shifts in raw material availability, regulatory guidance, and market dynamics, stakeholders can cultivate resilient operations that align with both current obligations and future aspirations. This introduction sets the stage for a comprehensive exploration of the forces driving the next chapter in GMP cell banking excellence.

How Emerging Technologies and Regulatory Evolution Are Redefining Standards for GMP Cell Banking Practices Worldwide

In recent years, the GMP cell banking landscape has been reshaped by a confluence of technological innovations and regulatory transformations. Automated high-throughput platforms now handle complex sample preparation and viability assessments with minimal human intervention, driving reproducibility while mitigating contamination risks. Concurrently, digital process control systems, empowered by artificial intelligence algorithms, enable predictive maintenance and adaptive feedback loops that sustain optimal culture conditions.

At the same time, regulatory authorities across major markets are harmonizing guidelines to reflect contemporary manufacturing practices. Updated frameworks emphasize risk-based approaches, process validation by design, and lifecycle management, placing a premium on comprehensive data integrity and real-time oversight. Manufacturers are responding by integrating quality management systems that seamlessly link laboratory information management with electronic batch records.

Moreover, strategic partnerships between instrument suppliers, cell therapy developers, and contract manufacturing organizations are accelerating the translation of research-stage cell lines into clinically compliant master and working banks. These collaborations foster knowledge exchange, expedite technology transfer, and support capacity expansion. As a result, the industry is witnessing a holistic shift toward end-to-end digitization, decentralized production footprints, and collaborative innovation networks that collectively elevate the standard of GMP cell banking.

Assessing the Far-Reaching Consequences of United States Tariffs in 2025 on Quality-Driven Cell Banking Operations and Global Biopharma Supply Security

The implementation of newly instituted tariffs by the United States in 2025 has introduced a complex layer of strategic considerations for cell banking operations that depend on cross-border sourcing of critical reagents and equipment. Raw materials such as specialized media components, cryoprotectants, and single-use consumables have been subject to elevated import duties, compelling organizations to reassess their procurement strategies and supply chain configurations.

Consequently, several manufacturers have turned to nearshoring initiatives and regional sourcing alliances to mitigate cost surges and maintain uninterrupted production cycles. These efforts are further supported by collaborative agreements with domestic suppliers who can offer localized warehousing, reduced lead times, and co-investment in quality certification processes. Nevertheless, some high-precision instrumentation and niche bioreagents remain reliant on established international suppliers, sustaining a degree of exposure to tariff-driven price inflation.

In response, innovative finance models such as dynamic pricing contracts and duty-deferred warehousing have emerged to buffer the impact on end users. Companies are also revisiting their inventory management protocols, balancing just-in-time delivery with strategic stockpiling for mission-critical components. As a result, the interplay between cost containment and supply chain resilience has become a defining theme for GMP cell banking stakeholders navigating the post-tariff environment.

Illuminating Detailed Cell Banking Market Segmentation Across Cell Types, Product Lines, Applications, End Users, Sources, Scale, Storage, Process Methodologies, and Distribution Channels

The cell banking market's complexity is rooted in a diverse array of cell types, each with distinct characteristics and demands. Insect cell lines, including Sf21, Sf9, and Tn5, excel in high-yield protein expression but require tailored culture conditions and viral vector systems. Mammalian hosts such as CHO and HEK293 cells offer unmatched compatibility for therapeutic glycoproteins, while NS0 and hybridoma lines underpin monoclonal antibody production. Microbial platforms likewise span bacterial systems like Bacillus species and E. coli strains, as well as yeast hosts such as Pichia pastoris and Saccharomyces cerevisiae, each balancing rapid growth with post-translational modification capabilities.

Beyond cell type, the differentiation between primary and working cell banks shapes storage protocols, quality testing cycles, and regulatory submissions. Primary repositories represent the definitive genetic baseline, whereas working banks enable scalable downstream processing. Applications range from clinical batch production to foundational research and development, demanding distinct validation and documentation pathways.

End-user segmentation further refines market dynamics. Academic research organizations, including government institutes and universities, drive fundamental discovery and early-stage validation, while biopharmaceutical companies prioritize commercial production alignment and regulatory compliance. Contract research organizations serve as pivotal partners for outsourcing specialized services. Sources of cell material, whether allogeneic from sibling or unrelated donors or patient-specific autologous origins, dictate donor screening workflows and chain-of-custody requirements.

Operational scale bifurcates into clinical-use banks for Phase I, II, and III studies and commercial-use banks that support full market launch. Storage technologies range from cryopreservation, which secures long-term viability under ultra-low temperatures, to lyophilization techniques that enable room-temperature stability under select conditions. Process modalities vary between fully automated systems designed for high throughput and manual workflows that offer flexibility for niche applications. Finally, distribution relies on a balance between direct sales channels, which afford end-to-end oversight, and specialized distributors capable of navigating regional regulatory frameworks and logistical complexities.

Unveiling Regional Dynamics Shaping Cell Banking Innovation and Adoption Patterns Across the Americas, Europe Middle East Africa and Asia Pacific Markets

Geographic dynamics exert a profound influence on the development and adoption of GMP cell banking solutions. Within the Americas, a well-established network of biopharmaceutical hubs in North America benefits from mature regulatory frameworks and deep pools of specialized talent. Cost structures and logistical efficiencies in Latin America are attracting strategic investments in regional production sites, particularly for biosimilar and vaccine initiatives, which complement local clinical trial demands.

Transitioning to Europe, the Middle East, and Africa, the regulatory landscape presents both harmonization opportunities and jurisdictional nuances. European Union directives promote centralized oversight and mutual recognition of supplier certifications, while emerging markets in the Middle East and Africa are prioritizing capacity building and technology transfer programs. These regions collectively leverage cross-border trade agreements to facilitate equipment importation and collaborative research partnerships.

Asia-Pacific is experiencing rapid growth driven by government-sponsored biotechnology clusters in China, India, Japan, and South Korea. Incentive programs and public-private partnerships are accelerating the construction of state-of-the-art cell banking facilities. Cost advantages and expanding local manufacturing capabilities are capturing the interest of multinational firms seeking to diversify production footprints. As a result, Asia-Pacific has become a focal point for strategic alliances, joint ventures, and commercial expansions that will shape the next wave of global cell banking innovation.

Profiling Leading Cell Banking Service Providers Driving Technological Innovation, Operational Excellence, and Strategic Collaborations in the Global Biomanufacturing Landscape

Leading service providers in the GMP cell banking arena are distinguished by their commitment to technological leadership, operational scalability, and collaborative agility. Several global entities have established multi-facility footprints, integrating automated cryostorage units with advanced analytics platforms to support high-volume sample throughput. These organizations maintain extensive reagent and consumable inventories to guarantee rapid turnaround times and minimize supply chain disruptions.

Strategic partnerships between cell line developers and contract manufacturing organizations have unlocked co-development pathways for proprietary expression systems. Meanwhile, technology licensors are forging alliances with instrumentation companies to seamlessly integrate closed-system bioreactors and in-line monitoring solutions into cell banking workflows. Cross-industry collaborations are also facilitating the standardization of assay protocols and quality benchmarks, which accelerates regulatory approvals and fosters mutual recognition of master cell bank certifications.

Furthermore, a select group of innovative providers is exploring decentralized cell banking models that leverage distributed network architectures, enabling clients to deploy satellite cryostorage units under centralized data governance frameworks. These flexible offerings cater to diverse scales of operation, from early-stage research projects to large-scale commercial programs. By combining end-to-end process validation with real-time digital dashboards, these market leaders are defining new service benchmarks for reliability, transparency, and customer responsiveness.

Strategic Imperatives and Proactive Initiatives for Industry Leaders to Advance Compliance, Scalability, and Innovation in GMP Cell Banking Operations

Industry leaders aiming to capitalize on the evolving GMP cell banking environment should prioritize strategic investments in automation and digital monitoring tools. By embedding real-time analytics and process control algorithms, organizations can significantly reduce variability and accelerate product release cycles. Concurrently, diversifying supply routes through regional sourcing partnerships and nearshoring initiatives will bolster resilience against tariff-induced cost pressures and transportation bottlenecks.

In parallel, proactive engagement with regulatory bodies is essential to anticipate guideline updates and to influence emerging standards. Establishing joint working groups and participating in industry consortia can provide early visibility into forthcoming policy shifts, enabling organizations to adapt documentation, validation, and risk management programs ahead of enforcement deadlines.

From an operational perspective, embracing a hybrid approach that combines centralized data repositories with decentralized cryostorage nodes enhances both oversight and flexibility. Coupling this with robust quality management systems ensures that donor screening, cell characterization, and chain-of-custody protocols remain consistent across multiple geographies. Finally, fostering collaborative innovation via academia-industry partnerships and joint R&D ventures will unlock novel cell line platforms and process intensification strategies, propelling the next generation of therapeutic breakthroughs.

Transparent and Rigorous Mixed-Method Research Methodology Underpinning Comprehensive Analysis of GMP Cell Banking Market Trends and Competitive Landscapes

This analysis is founded upon a rigorous mixed-methodology framework that integrates primary research, secondary data review, and expert validation. In the initial phase, in-depth interviews were conducted with a spectrum of stakeholders, including cell bank managers, quality assurance specialists, regulatory advisors, and equipment suppliers. These conversations yielded qualitative insights into operational pain points, technology adoption hurdles, and strategic priorities.

Simultaneously, an exhaustive secondary research effort aggregated technical white papers, regulatory guidance documents, company filings, and peer-reviewed studies. These sources were systematically evaluated to map historical trends, benchmark best practices, and identify emerging innovation pockets. Quantitative data sets were subjected to thorough cross-validation procedures, ensuring consistency and reliability across regional and segmental analyses.

Subsequent expert panels convened subject matter authorities to critique preliminary findings, refine segmentation frameworks, and stress-test hypothetical scenarios related to tariff fluctuations, regulatory reforms, and technology disruptions. The resulting triangulated insights reflect a consensus-driven perspective that balances forward-looking projections with empirical evidence. Throughout the research process, stringent data integrity protocols and confidentiality safeguards were maintained to uphold analytical transparency and stakeholder trust.

Integrating Insights to Navigate Future Opportunities and Mitigate Challenges in the Evolving GMP Cell Banking Ecosystem

As the GMP cell banking sector confronts an era of unprecedented technological advances, regulatory reshaping, and geopolitical influences, stakeholders must integrate multifaceted insights to chart a resilient course forward. The emergent paradigm centers on harmonizing automated process controls, agile supply chains, and collaborative innovation ecosystems to meet rising demands for biologic therapies and cell-based products.

Looking forward, success will hinge upon the ability to adapt to shifting tariff landscapes, harness data-driven decision frameworks, and establish strategic partnerships that transcend traditional industry boundaries. Organizations that proactively refine their quality management architectures and engage in policy dialogues will be best positioned to navigate upcoming guideline changes and market entry requirements.

Ultimately, the convergence of digital biomanufacturing tools, precision analytics, and decentralized cell storage networks offers a compelling blueprint for sustainable growth. By embracing this integrated approach, stakeholders can unlock new avenues of differentiation, accelerate time-to-clinic, and ensure the consistent delivery of safe, high-quality cell banks that underpin the next generation of therapeutic innovations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of automation technologies in GMP cell banking to enhance reproducibility and throughput
  • 5.2. Implementation of closed-system bioprocessing to minimize contamination risk during cell bank production
  • 5.3. Integration of real-time analytics and digital monitoring for enhanced GMP cell banking quality assurance
  • 5.4. Adoption of allogeneic cell therapies driving demand for scalable GMP cell banking infrastructure and capacity
  • 5.5. Standardization of cryopreservation protocols to improve long-term stability and viability of therapeutic cell banks
  • 5.6. Strategic partnerships between CDMOs and biotech companies expanding regional GMP cell banking network presence
  • 5.7. Regulatory harmonization efforts to streamline international approval of GMP-grade cell therapy products for cell banks

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. GMP Cell Banking Services Market, by Service Type

  • 8.1. Introduction
  • 8.2. Cell Banking & Storage
  • 8.3. Cell Line Development & Characterization
  • 8.4. Regulatory Support & Documentation
  • 8.5. Testing & Quality Control
    • 8.5.1. Adventitious Agent Testing
    • 8.5.2. Genetic Stability Testing
    • 8.5.3. Identity Testing
    • 8.5.4. Purity Testing
    • 8.5.5. Sterility Testing

9. GMP Cell Banking Services Market, by Cell Type

  • 9.1. Introduction
  • 9.2. Insect Cells
  • 9.3. Mammalian Cells
    • 9.3.1. CHO Cells
    • 9.3.2. HEK293 Cells
    • 9.3.3. NS0/Sp2 Cells
    • 9.3.4. Vero Cells
  • 9.4. Microbial Cells
    • 9.4.1. Bacterial Cells
    • 9.4.2. Yeast Cells
  • 9.5. Stem Cells
    • 9.5.1. Embryonic Stem Cells
    • 9.5.2. Induced Pluripotent Stem Cells (iPSCs)
    • 9.5.3. Mesenchymal Stem Cells (MSCs)

10. GMP Cell Banking Services Market, by Cell Bank Type

  • 10.1. Introduction
  • 10.2. End-of-Production Cell Bank (EOPCB)
  • 10.3. Master Cell Bank (MCB)
  • 10.4. Research Cell Bank (RCB)
  • 10.5. Working Cell Bank (WCB)

11. GMP Cell Banking Services Market, by Application

  • 11.1. Introduction
  • 11.2. Biopharmaceutical Production
    • 11.2.1. Gene & Cell Therapies
    • 11.2.2. Monoclonal Antibodies
    • 11.2.3. Recombinant Proteins
    • 11.2.4. Vaccines
  • 11.3. Cell Therapy
  • 11.4. Drug Discovery & Development
  • 11.5. Tissue Engineering & Regenerative Medicine

12. GMP Cell Banking Services Market, by End User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Contract Research & Manufacturing Organizations
  • 12.4. Hospitals & Clinics
  • 12.5. Pharmaceutical & Biotechnology Companies

13. Americas GMP Cell Banking Services Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa GMP Cell Banking Services Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific GMP Cell Banking Services Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. 53Biologics
    • 16.3.2. Austrianova
    • 16.3.3. Cell Culture Company, LLC
    • 16.3.4. Charles River Laboratories
    • 16.3.5. Clean Cells
    • 16.3.6. Eurofins Scientific Limited
    • 16.3.7. ExcellGene SA
    • 16.3.8. Goodwin Biotechnology Inc.
    • 16.3.9. Kaneka Eurogentec S.A.
    • 16.3.10. Lonza Group Ltd.
    • 16.3.11. Merck KGaA
    • 16.3.12. NAOBIOS
    • 16.3.13. PackGene Biotech lnc.
    • 16.3.14. ProBio Biotech Corporation
    • 16.3.15. RoslinCT
    • 16.3.16. SGS Group
    • 16.3.17. SK pharmteco Inc.
    • 16.3.18. Takara Bio Inc.
    • 16.3.19. Texcell SA
    • 16.3.20. uBriGene Biosciences International Co.
    • 16.3.21. ViruSure GmbH
    • 16.3.22. Wacker Chemie AG
    • 16.3.23. WuXi Biologics
    • 16.3.24. OmniaBio
    • 16.3.25. eXmoor pharma concepts ltd

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. GMP CELL BANKING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. GMP CELL BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. GMP CELL BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. GMP CELL BANKING SERVICES MARKET: RESEARCHAI
  • FIGURE 26. GMP CELL BANKING SERVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 27. GMP CELL BANKING SERVICES MARKET: RESEARCHCONTACTS
  • FIGURE 28. GMP CELL BANKING SERVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. GMP CELL BANKING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANKING & STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANKING & STORAGE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL LINE DEVELOPMENT & CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL LINE DEVELOPMENT & CHARACTERIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGULATORY SUPPORT & DOCUMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGULATORY SUPPORT & DOCUMENTATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ADVENTITIOUS AGENT TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ADVENTITIOUS AGENT TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENETIC STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENETIC STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY IDENTITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY IDENTITY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PURITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PURITY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STERILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HEK293 CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HEK293 CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY NS0/SP2 CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY NS0/SP2 CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VERO CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VERO CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS (IPSCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS (IPSCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS (MSCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS (MSCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-OF-PRODUCTION CELL BANK (EOPCB), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-OF-PRODUCTION CELL BANK (EOPCB), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MASTER CELL BANK (MCB), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MASTER CELL BANK (MCB), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH CELL BANK (RCB), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH CELL BANK (RCB), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY WORKING CELL BANK (WCB), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY WORKING CELL BANK (WCB), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENE & CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENE & CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 205. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 207. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 225. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 226. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 227. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 279. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 291. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
  • TABLE 297. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
  • TABLE 299. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
  • TABLE 300. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. FRANCE GMP CELL BANK